These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35641264)
1. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells. Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264 [TBL] [Abstract][Full Text] [Related]
2. Astilbin Induces Apoptosis in Oral Squamous Cell Carcinoma through p53 Reactivation and Mdm-2 Inhibition. Wu A; Zhao C Dokl Biochem Biophys; 2024 Oct; 518(1):429-441. PubMed ID: 39196525 [TBL] [Abstract][Full Text] [Related]
3. p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. Roh JL; Kang SK; Minn I; Califano JA; Sidransky D; Koch WM Oral Oncol; 2011 Jan; 47(1):8-15. PubMed ID: 21109480 [TBL] [Abstract][Full Text] [Related]
4. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer. Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494 [TBL] [Abstract][Full Text] [Related]
5. RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway. Surget S; Descamps G; Brosseau C; Normant V; Maïga S; Gomez-Bougie P; Gouy-Colin N; Godon C; Béné MC; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C BMC Cancer; 2014 Jun; 14():437. PubMed ID: 24927749 [TBL] [Abstract][Full Text] [Related]
6. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma. Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996 [TBL] [Abstract][Full Text] [Related]
7. Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells. Son HK; Kim D Asian Pac J Cancer Prev; 2023 Jan; 24(1):283-289. PubMed ID: 36708578 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro. Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164 [TBL] [Abstract][Full Text] [Related]
9. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic effect of CKD-602 (Camtobell) on oral squamous cell carcinoma cell lines. Ok YJ; Myoung H; Kim YK; Lee JH; Kim MJ; Yun PY Oral Oncol; 2009 Mar; 45(3):266-72. PubMed ID: 18715816 [TBL] [Abstract][Full Text] [Related]
11. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation. Ma T; Yamada S; Ichwan SJ; Iseki S; Ohtani K; Otsu M; Ikeda MA Biochem Biophys Res Commun; 2012 Jan; 417(3):931-7. PubMed ID: 22166212 [TBL] [Abstract][Full Text] [Related]
12. Mutated and non-mutated TP53 as targets in the treatment of leukaemia. Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636 [TBL] [Abstract][Full Text] [Related]
13. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. Nakazawa S; Sakata KI; Liang S; Yoshikawa K; Iizasa H; Tada M; Hamada JI; Kashiwazaki H; Kitagawa Y; Yamazaki Y Biomed Res; 2019; 40(1):37-49. PubMed ID: 30787262 [TBL] [Abstract][Full Text] [Related]
14. Quantitative phosphoproteomic analysis reveals γ-bisabolene inducing p53-mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation. Jou YJ; Chen CJ; Liu YC; Way TD; Lai CH; Hua CH; Wang CY; Huang SH; Kao JY; Lin CW Proteomics; 2015 Oct; 15(19):3296-309. PubMed ID: 26194454 [TBL] [Abstract][Full Text] [Related]
15. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. Alam M; Mishra R Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459 [TBL] [Abstract][Full Text] [Related]
16. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma. Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707 [TBL] [Abstract][Full Text] [Related]
17. The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells. Chuang HC; Yang LP; Fitzgerald AL; Osman A; Woo SH; Myers JN; Skinner HD PLoS One; 2014; 9(8):e104821. PubMed ID: 25119136 [TBL] [Abstract][Full Text] [Related]
18. Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome. Wu G; Guo Y; Liu Y; Cai X; Deng T; Pei T; Huang L; Chen K; Pan X J Immunol Res; 2023; 2023():5293677. PubMed ID: 36969496 [TBL] [Abstract][Full Text] [Related]
19. [Effect of RITA on TP53 Mutant Human Mantle Cell Lymphoma Cell Line and Its Mechanism]. Hua JY; Zhou XH; Wang Y; Xu B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1780-1784. PubMed ID: 34893110 [TBL] [Abstract][Full Text] [Related]
20. Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosis. Imai Y; Ohnishi K; Yasumoto J; Kajiwara A; Yamakawa N; Takahashi A; Ohnishi T; Kirita T Oral Oncol; 2005 Jul; 41(6):631-6. PubMed ID: 15975526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]